biocompanies have found their place...nanobiotechnology, including drug delivery. outside the health...

20
Biocompanies have found their place

Upload: others

Post on 17-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

Biocompanies have found their place

Page 2: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise
Page 3: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

Welcome tothe Basque bioRegion

Page 4: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

04

A key to this transformation was the development of a specific results-driven biosciences policy known as BioBasque 2010, implementedfrom 2002 with the participation of all relevant stakeholders.

Strong government support, with a pro-business orientation, hashelped a thriving biosciences community, promoted the collaborationbetween the academic world, the health system and industry; andcontributed essential infrastructures.

Proven experience in clustering (we are pioneers in Spain) has alsoworked to create a nourishing environment that acts as a magnet fortalent. More than 60 % of the expanding researcher pool comes fromvarious parts of Europe, America and Asia. Within a favourableframework, the private sector —attentive to technological revolutions—and the entrepreneurial spirit are added assets that become enginesfor consolidating the biocluster.The growing biocluster is geared to success by a combination of:

• A clear vision.

• Shared objectives.

• Coordination of activities.

The Basque bioRegion is defined by a distinctive trait, Convergence,derived from a unique concentration of skills and cross-disciplinaryresearch, at frontiers where several disciplines meet.

The business sector, with more than 65 companies, is not only biotechand benefits from cumulated expertise. Biological know-how iscomplemented by a tradition in engineering, manufacturing,microtechnology, electronics, robotics and automation, and by thenewer skills in nanotechnology.

No other region of the size of the Basque Country offers a comparableblend and the opportunity to integrate advanced solutions into complexproducts.

But for sustained success, the Basque bioRegion is also connected tothe world. Strong ties have been established with the internationalscientific community through active participation in global networkssuch as the Human Proteome Organization (HUPO) initiative,collaborative relationships within Europe, among which the ERANETprogramme, or direct participation in networks such as the CEBR(Council of European Bioregions). The business sector is also representedin EuropaBio, and key elements of the Innovation System are connectedto their peers in various associations.

From a strong heritage of industrial success, the Basque Country has turned itselfinto a small but vibrant bioRegion, with a growing cluster of life science companiesrooted in a renovated research and innovation system.

Local assets for a global scene

Page 5: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

05

22

3Favourable

financial andtax system.

4 Specificbioscience policy:

5 Stronggovernment

support, with apro-businessorientation.

6

7 Unique blendof converging

technologies andknow-how.

Connected tothe world.

8

1Growing clusterof life sciencecompanies.

Strong heritageof industrialsuccess, and

entrepreneurialspirit.

Collaborationbetween the

academic world,the health system

and industry.

Short distancesfacilitate collaboration.It takes under two hours

by car to travel within thebioregion and to connect

relevant stakeholders.

Page 6: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

Universities, Cooperative Research Centres, the Health System, and Technology Centresjoin efforts to generate and apply knowledge.

Page 7: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

CIC bioGUNE (Cooperative Research Centre)Centre of excellence focused on biomedicine and biotechnology forthe diagnosis, prevention and treatment of human diseases. Includestop-notch core facilities (genotyping, gene silencing, proteomics andmetabolomics, cytogenomics), and a powerful Structural Biology Unit.

CIC biomaGUNE (Cooperative Research Centre)Centre of excellence focused on biomaterials and nanobiotechnology,studying biosurfaces, biosensors, molecular imaging and drug delivery.At the interface of biology, chemistry and physics, it counts on asingular Molecular Imaging Unit (fully operational in 2008).

CIC microGUNE and CIC nanoGUNECooperative Research Centres devoted to micro and nanotechnologies,respectively, with applications in life sciences.

Healthcare and hospital systemIncreasingly oriented to research, it works along the academic andbusiness worlds complementing basic and clinical research, andpromoting clinical trials.

Technological Corporations Tecnalia and IK4They contribute industrial expertise and complement biology-relatedresearch with converging technologies such as manufacturing,engineering, materials, electronics, electrochemistry and automation,of relevance for the integration and design of final products.

University of the Basque Country, UPV/EHUBiggest university with inter-disciplinary research in some 20Departments related to biosciences, and particular strengths inBiophysics, Physics and Chemistry. Competences in life sciences arecomplemented by engineering and business studies.

University of DeustoLong-established university, renowned for social and business studies,and for commercial awareness. Together with the UPV/EHU, it runsa pioneering Chair of Law and Human Genome and carries out leadingresearch in bioethical aspects.

07

The foundations: science and technology

An educated workforce is the basis of a comprehensive Science, Technology and Innovation Network, which works in collaboration with privatecompanies in various life sciences sectors. This research and technology base draws its strength from convergence, relies upon co-operationand is organised in “Knowledge Communities” that create new innovative dynamics.

Page 8: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

Medical imageMaterials research

Biophysics Genomics

Proteomics Metabolomics

Bioinformatics Glycobiotechnology

Plant Biotechnology Nanobiotechnology

Cell biology, Stem Cells and Tissue Engineering

Organic, Pharmaceutical, and Polymer Chemistry

Macro and Micromechanics Electrochemistry

MicrofluidicsMicromachining tools

Robotics Automation

Nanotechnology

Molecular Imaging:MRI, SPECT-CT, PET-CT,

Cyclotron & Radiopharmacy.

Structural Biology:Electron Microscopy,

NMR, X-ray.

State-of-the-artspecialised facilities

Capacities and expertise

08

Page 9: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

09

Application fields

• Biomarkers, Drug discovery and Personalised Medicine• Drug delivery• Orthopaedics and Regenerative Medicine• Biosensors and bioanalytics• Medical technologies and devices• Bioproduction• Biocleaning• Food safety, nutrition and health• Tools and equipment

Autoimmune diseasesHepatology

NeurosciencesDiabetes, obesity and metabolic disorders

OncologyInfectious diseases

Inflammation

Health

Industrial biotechnology

Agro-food

The existing capacities and expertise available within BioBasque, togetherwith the breadth of the life science field offers multiple opportunitiesfor research, and the cross-technology synergies pave the way for thedevelopment of particular applications. BioBasque is, in fact, built onconvergence and on a cooperation spirit stemming from pioneeringcollaborative programmes established two decades ago.

Research activity in biomarkers, drug discovery and drug delivery issignificant and benefits from integrated, interdisciplinary approachesthat bring together biology, chemistry, physics, and nanotechnology.Diagnostic applications are also developed with the concourse ofelectronic, software, and engineering expertise among others. Researchcovers several therapeutic areas, with distinctive traits in hepatology,autoimmune and inflammatory diseases, neuroscience (Parkinson,Alzheimer, depression, bipolar disorders and schizophrenia), oncology,and infectious diseases.

Research in biomaterials, scaffolds, stem cells and use of othertechnologies are also aimed at applications in Regenerative Medicineand in Orthopaedics, with special emphasis in bone regeneration,dental, ophthalmology and surgery. Other growing applications arebiosensors and bioanalytics (e.g. lab-on-a-chip), of use not only inhealthcare but also in food and environmental care.

Page 10: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

A diversified biocluster

10

Page 11: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

11

Page 12: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

More than 65 companies reflect a diversified sector, on the increase by new entrantscontinuing the entrepreneurial tradition.

A growing business sector

Main areas of activity

13 % Industry and environment

16 % Animal health and agrofood

63 % Human health

8 % Others

Main types of products

37 % Biotechnology products

16 % Pharmaceutical products

16 % Services

14 % Biomaterials

17 % Diagnostics

12

Biosciences are growing strong in the Basque Country. Since 2001, whenthe government and key stakeholders launched the BioBasque 2010strategy, a company is created every 3 months. The region totals 66biocompanies that reflect a diversified sector in which, nonetheless, thehuman health field concentrates most of the activities, companies,employees, R&D investment, and turnover.

Many life sciences companies can be found along the biopharmaceuticalvalue chain, from discovery, screening and validation (platforms,animal models, etc.) to development, clinical assays andcommercialisation. There are particular strengths in biomarkers anddiagnostic activity, and some companies are reference in niches withinthe area of Personalised Medicine. Other companies develop newchemical entities, offer in vivo High Content Screening, produce cellsand biomolecules with therapeutic activities, provide contract researchand manufacturing expertise, or commercialise bioinformatic software.

Page 13: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

13

Bright young start-ups continue a tradition in entrepreneurship

Number of companies: Origin of start-ups:

36 % Academic

39 % Private

17 % Technology centres

8 % Medical · Health

35

301998 1999 2000 2001 2002 2003 2004 20051997 2006

40

45

50

55

60

65

70

An additional group of companies are active in the fields of Biomaterials,Medical devices, Orthopaedics, Implantology and RegenerativeMedicine. Some are also developing new applications derived fromnanobiotechnology, including drug delivery.

Outside the health area, other companies use industrial biotechnologyapproaches to commercialise products or processes for a great varietyof sectors, including the agro-food and beverages, cosmetic, chemicaland environment. Diagnostics are competitive niches for food safety,environment and veterinary fields, and an increasing number ofcompanies are developing biosensors and related equipment, supportedby the Bioregion expertise in manufacturing, engineering andconverging technologies.

The biocluster is geared by agile start-ups accompanied by solid, wellestablished companies that provide the necessary financial andcommercial muscle, and the company structure is maturing by furtherindustrial diversification and by consolidation phenomena taking place,reflected in the creation of the first biobusiness corporations.

Page 14: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

An efficient Health System, geared by innovation, is the best partner for new developments,from discovery to clinical research.

The clinical environment

The Public Health System of the Basque Country (Osakidetza) hasbeen a reference due to the excellence of its healthcare and thepioneering implementation of innovative management systems. Thenetwork is composed of 51 hospitals and 442 primary attention centres,where 24,000 professionals work (4.5 doctors per 1,000 inhabitants).But with 7 main hospitals, of which 4 are university hospitals, ResearchUnits and Experimental Units, the clinical environment also offers astill very much untapped potential for research. There are EthicalCommittees in the main hospitals and 1 Regional Committee forcoordination of multicentre studies.

Since the year 2002, research activities have been improved by thecreation of BIOEF, the Basque Foundation for Research and Innovationin Health, which facilitates links between preclinical and clinicalactivities.

The Health System provides equal and free access to all citizens inthe Basque Country. Medical records are linked to the individual healthcard, and a centralised system ensures the reliability of such records,with common processes and protocols, and the capacity to trackpatients over time.

The system is further enhanced by the existence of well characterised,population-based biobanks (tissue and DNA banks) and comprehensivedatabases useful for research:• In-patient healthcare register.• Mental health register.• Cancer register.• Morbidity and mortality registries.• Longitudinal studies, lifestyle habits, and a detailed Health survey.

The existence of well-defined patient cohorts is nowadays improvedby the ability to genotype. And traces of rather isolated populationsin the Basque Country offer an added value to study genetic variantsof relevance to disease or therapeutic response.

The Health System conducts Phase I and Phase II trials, in addition tothe more common Phase III trials. And additional clinical services arealso provided by local CROs. In all, the Basque bioRegion offers GCP-approved clinical units and services ranging from pharmacokineticsand pharmacodynamics, to bioavailavility, bioequivalence, ADME-Toxand interaction studies.

Increasing levels of cooperation between industry, university, researchcentres and hospitals facilitate more agile introduction of newdevelopments in clinical environments, for example by access toplatform technologies.

14

Page 15: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

15

The Basque Health System assets

Social securitynumber

Good bioethicalclimate

Clinicalenvironment

Databanks andregisters

Autochthonousand residentpopulations

Main Hospitals:

Cruces Hospital

Basurto Hospital

Galdakao Hospital

Donostia Hospital

Oncology Institute of San Sebastian

Txagorritxu Hospital

Santiago Apostol Hospital

Page 16: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

The Basque Innovation System is an extended networkthat enables the transformation of good ideas into solid companies.

Innovation System: the road to success

With Technology Transfer Offices at universities and research ortechnology centres, plus a set of incubators, ideas are rapidly exploitedor transformed into companies. In fact, the entire Innovation Systemis focused on the creation and consolidation of biocompanies, in aprocess that contributes a ready flow of high growth, high technologypotential investment opportunities.

A key element in the system is the network of Basque BusinessInnovation Centres, which promote innovative and technologicallyadvance enterprises and projects. The network is led by tutors thatoperate with networks of expert contacts, providing thus advancedservices, in addition to infrastructures.

The network has been recently reinforcedby the addition of a bioincubator that offersspecialised facilities and support to start-ups and entrepreneurs.

The Basque Country boasts a unique Network of Technology Parks.Either for a start-up or for an established firm, Technology Parks areoften the preferred location for biocompanies, as they provide space(with room for growth), state-of-the-art infrastructures and addedvalue services to facilitate the innovation process.

New or incoming businesses find a nurturing environment in theParks, as these also house University departments, Centres of Excellenceand other companies. The Parks and their surroundings (where hospitalscan also be found) are the main nuclei of the growing Basque biocluster.The innovation system is connected internationally through participationin networks ad associations such as the International Association ofScientific Parks (IASP) or the European BIC Network (EBN).

Additionally, other institutions provide specific support for businessinternationalisation on the route to commercialisation in a globalmarket. And help is provided by the Biobasque Agency, whichrepresents the Basque Bioregion and acts as interface and coordinatorof stakeholders.

1 An attractive start-up package.

2 Access to public and private finance.

3 A competitive business environment.

4 Highly qualified personnel.

5 Modern infrastructures.

Highlights

16

Page 17: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

03

Page 18: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

18

The Basque Country

The Basque Country is a unique land where age-old traditions and anancient language are intertwined with new technologies andinnovation, defining a modern and open society. A place whereadvanced medical care and high per capita income contribute to ahigh standard of living.

Visitors discover a privileged location with a mild climate and surprisinglyvaried landscape. Rough seas and charming coastlines meet themountains, forests, and green hillsides, while fertile fields are hometo renowned vineyards.Small villages are tucked away among these natural spaces, alongwith vibrant cities that preserve a rich heritage coexisting with modernarchitecture.

The landscape provides a perfect scenario for leisure activities rangingfrom the traditional rural sports to trekking, climbing, biking, golfingor surfing. But the cultural offer, diverse enough to satisfy all tastes,also includes Museums, Theatres, and an alluring music and art scenewith highlights such as the San Sebastian International Film Festivaland the Vitoria-Gasteiz Jazz Festival.And for everyday enjoyment, gastronomy also makes life in theBasque Country even more attractive. No significant event, includingbusiness, can take place without the luxury of first class cuisine andwine.

The hospitality and professionalism of the people are further majorreasons to visit or make business here, facilitated by good infrastructuresand connections to the rest of the world.

A good place to work and live.

At a glance

Area:

7,235 km2.

Population:

2,112,204 (5 % of Spain).

Main cities:

· Bilbao

· Donostia - San Sebastian

· Vitoria - Gasteiz

Official languages:

Basque and Spanish.

3 International airports.

5 Universities, more than 100 degrees, 100,000 students,and 6,500 lecturers.

51 hospitals, 442 primary attention centres, 24,000professionals, 4.5 doctors per 1,000 inhabitants.

125.5 % GDP per capita (compared to EU, 2005).

4.2 % annual GDP growth (2006).

Industrial tradition:

· 29 % contribution to GDP (2005), ten points above EU average.

· 10 % of all industrial production and 10 % of Spanishexports.

2/3 of R&D investment is of private origin.

An international leader in environmental and qualitycertificates.

© F

MG

B G

ugge

nhei

m B

ilbao

Mus

eoa,

Bilb

ao, 2

006

· Aut

hor:

Eri

ka B

arah

ona

Ede

| © A

rchi

vo “

Arg

azki

” Eu

sko

Jaur

lari

tza

- G

obie

rno

Vasc

o · A

utho

r: M

ikel

Arr

azol

a

Page 19: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise
Page 20: Biocompanies have found their place...nanobiotechnology, including drug delivery. Outside the health area, other companies use industrial biotechnology approaches to commercialise

[email protected]

INDUSTRIA, MERKATARITZAETA TURISMO SAILA

DEPARTAMENTO DE INDUSTRIA,COMERCIO Y TURISMO